Dialogues on diversifying clinical trials: Successful strategies for engaging women and minorities in clinical trials

Journal of Women's Health

Volumn 21, Issue 7, 2012, Pages 713-716

  Coakley, Meghan ^a,b   Fadiran, Emmanuel Olutayo ^c   Parrish, L Jo ^d   Griffith, Rachel A ^d   Weiss, Eleanor ^d   Carter, Christine ^d  

^a National Institute of Health ^*  (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d Society for Women's Health Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); COMMUNICATION SKILL; COMMUNITY CARE; FEMALE; FEMALE PHYSICIAN; GENDER; HEALTH CARE DISPARITY; HUMAN; MEDICAL ETHICS; MEDICAL TECHNOLOGY; MINORITY GROUP; PATIENT EDUCATION; PATIENT PARTICIPATION; PREVALENCE; PRIORITY JOURNAL; PUBLIC-PRIVATE PARTNERSHIP; RACE; REVIEW; RISK ASSESSMENT; TRUST;

EID: 84863705447     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2012.3733     Document Type: Review

References (11)

1. Dhruva SS, Bero LA, Redberg RF. Gender bias in studies for Food and Drug Administration premarket approval of cardiovascular devices. Circulation 2011;4:165-171.
2. Kanarek NF, Tsai H, Metzger-Gaud S, et al. Geographic proximity and racial disparities in cancer clinical trial participation. J Natl Compr Canc Netw 2010;8:1343-1351.
3. Anderson GD. Sex and racial differences in pharmacological response: Where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamics. J Womens Health 2005:14:19-29.
4. Zopf Y, Rabe C, Neubert A, et al. Women encounter ADRs more often than do men. Eur J Clin Pharmacol 2008;64:999-1004.
5. Phan VH, Moore MM, McLachlan AJ, Piquette-Miller M, Xu H, Clarke SJ. Ethnic differences in drug metabolism and toxicity from chemotherapy. Exp Op Drug Metab Toxicol 2009;5:243-257.
6. Rotger M, Csajka C, Telenti A. Genetics, ethnic and gender differences in the pharmacokinetics of antiretrovival agents. Curr HIV/AIDS Rep 2006;3:118-125.
7. Dirks NL, Huth B, Yates CR, Meibohm B. Pharmacokinetics of immunosuppressants: A perspective on ethnic differences. Int J Clin Pharacol Ther 2004;42:701-718.
8. Schaefer BM, Carcciolo V, Frishman WH, Charney P. Gender, ethnicity and genetics in cardiovascular disease: Part 1: Basic principles. Heart Dis 2003;5:129-143.
9. Mosca L, Linfante AH, Benjamin EJ, et al. National Study of Physician Awareness and Adherence to Cardiovascular Disease Prevention Guidelines. Circulation 2005;111: 499-510.
10. Coberley CR, Puckrein GA, Dobbs AC, McGinnis MA, Coberley SS, Shurney DW. Effectiveness of disease management programs on improving diabetes care for individuals in health-disparate areas. Dis Management 2007;10:147-155.
11. U.S. Department of Health and Human Services, Food and Drug Administration. Advancing regulatory science at FDA: A strategic plan, 2011. Available at www.fda.gov/downloads/ ScienceResearch/SpecialTopics/ RegulatoryScience/UCM268225 .pdf Accessed November 9, 2011.